SCHEMBL15046472

SCHEMBL15046472

CC(=O)Cc1nc(-c2ccc(C)cc2)cn1-c1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.49
MAPT P10636 5/20 0.48
ALDH1A3 P47895 1/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
GABRB2 P47870 3/20 0.44
GABRA2 P47869 1/20 0.44
TP53 P04637 1/20 0.43
GABRA1 P14867 2/20 0.41
RAB9A P51151 3/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
KMT2A Q03164 1/20 0.40
PTGS1 P23219 1/20 0.40
F2 P00734 1/20 0.38
ALDH1A1 P00352 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15043866 0.95 GABRB2 (0.45) ABCB1MAPTALDH1A3SMN1; SMN2GABRB2
SCHEMBL15034001 0.90 MAPT (0.51) ABCB1MAPTALDH1A3SMN1; SMN2GABRB2
SCHEMBL15046476 0.87 MAPT (0.52) MAPTSMN1; SMN2GABRB2GABRA2RAB9A
SCHEMBL15046477 0.86 GRM5 (0.43) ABCB1MAPTGABRB2GABRA2PTGS1
SCHEMBL15033936 0.86 GABRA2 (0.52) ABCB1MAPTALDH1A3SMN1; SMN2GABRB2
SCHEMBL15033978 0.83 GABRA2 (0.43) MAPTSMN1; SMN2GABRB2GABRA2TP53
SCHEMBL15046461 0.82 GABRA2 (0.42) MAPTSMN1; SMN2GABRB2GABRA2TP53
SCHEMBL15019885 0.82 GABRA2 (0.42) MAPTSMN1; SMN2GABRB2GABRA2TP53
SCHEMBL15020142 0.81 GABRA2 (0.55) MAPTSMN1; SMN2GABRB2GABRA2TP53
Lithium Ion SCHEMBL15019886 0.81 GABRB2 (0.41) ABCB1MAPTSMN1; SMN2GABRB2GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013087806-A1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 WO disclosed